The luteal phase after hyperstimulation for in vitro fertilization.

Area of Science:

• Reproductive Endocrinology
• In Vitro Fertilization (IVF)
• Luteal Phase Physiology

Background:

• In vitro fertilization (IVF) involves complex hormonal cycles and interventions.
• Understanding luteal phase dynamics is crucial for successful implantation and pregnancy.
• Hyperstimulation protocols using clomiphene citrate and human menopausal gonadotropin (hMG) are common in IVF.

Purpose of the Study:

• To investigate luteal phase steroid production in conceptual versus nonconceptual IVF cycles.
• To explore potential correlations between steroid levels and cycle outcomes.
• To assess the need for luteal-phase support in patients undergoing specific IVF stimulation protocols.

Main Methods:

• Retrospective analysis of 500 in vitro fertilization (IVF) cycles.
• Monitoring of urinary total estrogen (UTE) and pregnanediol excretion (Pd2) levels.
• Hormonal assays and assessment of luteal phase length (≥10 days).

Main Results:

• Elevated midluteal UTE and Pd2 levels were observed, consistent with hyperstimulation.
• Pregnanediol glucuronide peaked around luteal day 6, rising again with implantation.
• Estradiol levels showed a trend towards earlier decline in nonconceptual cycles, though not statistically significant.

Conclusions:

• Some nonconceptual IVF cycles may experience early corpus luteal regression.
• The pattern of steroid production in the follicular phase was similar in both cycle types.
• Controlled studies on luteal-phase support are recommended for patients stimulated with clomiphene/hMG and hMG alone, particularly given potential cycle compression with hMG therapy.